Management of colorectal liver metastases: New Data

Monday, March 31, 2025

8:30 AM – 9:45 AM CT

Location: Music City Center, 209 ABC

CE: 1.25

Content Level: 200 (intermediate)

Coordinator(s)

Nadine Abi-Jaoudeh, MD, FSIR

Professor of Radiology
University of California, United States
Constantinos Sofocleous, MD PhD

Professor IR
Weill Cornell Medical College Memorial Sloan-Kettering Cancer Center, United States

In the session a review of various therapeutic options for the management of liver metastasis including considerations of mutations, disease biology in the management of colorectal metastases as well as review of recent literature.

Learning Objectives:

Understand current guidelines for the management of colorectal metastasis with different chemotherapeutic regimens and considering targeted therapies based on mutations and biomarkers.
Discuss various management options for liver only and liver dominant disease: from local cure to the chemo refractory salvage setting.
Know new evidence for locoregional therapies in the management of lmCRC.

Presentations:

8:30 AM – 8:45 AM CT

Management of Colorectal Carcinoma Per Guidelines and Updates
Speaker: Bruno C. Odisio, MD, PhD, FSIR (he/him/his) – MD Anderson Cancer Center
8:45 AM – 9:00 AM CT

Role of Ablation vs Surgery in MCRC: Maverick, Collision and Other Trials
Speaker: Vlasios S. Sotirchos, MD – Memorial Sloan Kettering Cancer Center
9:00 AM – 9:15 AM CT

Updates on Intra-arterial Therapies for MCRC: HAI, Radioembolization; Segmentectomy vs Lobar, Dosimetry
Speaker: Daniel B. Brown, MD, FSIR (he/him/his) – Vanderbilt University Medical Center
9:15 AM – 9:30 AM CT

SBRT for Colorectal Metastasis: Is There a Role?
Speaker: Laura Dawson, MD (she/her/hers) – Dept Radiation Oncology, University of Toronto; Princess Margaret Cancer Centre/UHN
9:30 AM – 9:45 AM CT

Q&A